TrialBritish journal of clinical pharmacology2013

Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects.

José Francisco Rocha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.